RISE507
|
BARu |
Bronze Age |
Russia |
F |
-3322 |
-2923 |
U5a1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE508
|
BARu |
Bronze Age |
Russia |
F |
-3331 |
-2935 |
U5a1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE61
|
NESC |
Neolithic |
Denmark |
M |
-2851 |
-2492 |
J1c4 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE392
|
BARu |
Bronze Age |
Russia |
M |
-2126 |
-1896 |
J2b1a2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
15812A (MT-CYB): LHON (Reported / Secondary)
-
295T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE577
|
UNC |
Bronze Age |
Czech Republic |
F |
-2300 |
-1800 |
T2b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE349
|
BAHu |
Bronze Age |
Hungary |
F |
-2034 |
-1784 |
T2b3 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE374
|
BAHu |
Bronze Age |
Hungary |
M |
-1866 |
-1619 |
T2b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
I5020
|
BBC |
Copper Age |
Germany |
F |
-2457 |
-2205 |
H2a1e |
bam
|
151.53
|
|
FASTA
Metadata
|
|
|
I5044
|
EBACz |
Bronze Age |
Czech Republic |
F |
-2300 |
-1900 |
K1b1a |
bam
|
197.62
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
5913A (MT-CO1): Prostate Cancer / hypertension (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE154
|
UNC |
Bronze Age |
Poland |
F |
-1925 |
-1765 |
K1a4a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE480
|
BAHu |
Bronze Age |
Hungary |
F |
-1700 |
-1500 |
U5a2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE546
|
YAM |
Bronze Age |
Russia |
M |
-3000 |
-2400 |
U5a1d2b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE552
|
YAM |
Bronze Age |
Russia |
M |
-2849 |
-2143 |
T2a1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
14687G (MT-TE): Mito myopathy w respiratory failure / intellectual disability (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE1
|
CWC |
Neolithic |
Poland |
U |
-2865 |
-2578 |
K1b1a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE145
|
UNC |
Bronze Age |
Poland |
M |
-2188 |
-1958 |
H6a1b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE493
|
BARu |
Bronze Age |
Russia |
M |
-1531 |
-1427 |
C4a1c |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE494
|
BARu |
Bronze Age |
Russia |
M |
-1416 |
-1268 |
I4a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE497
|
BARu |
Bronze Age |
Russia |
M |
-1414 |
-1261 |
A+152+16362 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE499
|
BARu |
Bronze Age |
Russia |
F |
-1496 |
-1306 |
H5a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE515
|
BARu |
Bronze Age |
Russia |
F |
-2340 |
-2145 |
A8a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE516
|
BARu |
Bronze Age |
Russia |
F |
-2201 |
-2036 |
H6a1b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE525
|
BARu |
Bronze Age |
Russia |
U |
-1598 |
-1398 |
I5c |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE598
|
BABL |
Bronze Age |
Lithuania |
M |
-908 |
-485 |
H2a2 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
I5035
|
EBACz |
Bronze Age |
Czech Republic |
F |
-2300 |
-1900 |
T2b |
bam
|
283.43
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE175
|
BASC |
Bronze Age |
Sweden |
M |
-1395 |
-1132 |
T1a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE210
|
BASC |
Bronze Age |
Sweden |
M |
-1432 |
-1292 |
T2a1a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE47
|
BASC |
Bronze Age |
Denmark |
M |
-1499 |
-1324 |
I |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE276
|
BASC |
Bronze Age |
Denmark |
M |
-794 |
-547 |
T2b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE179
|
NESC |
Neolithic |
Sweden |
M |
-2010 |
-1776 |
K1a3 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE71
|
NESC |
Neolithic |
Denmark |
F |
-2196 |
-2023 |
H3b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE97
|
NESC |
Neolithic |
Sweden |
F |
-2025 |
-1885 |
K2a5 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE98
|
NESC |
Neolithic |
Sweden |
M |
-2275 |
-2032 |
K1b1a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE486
|
BAIt |
Bronze Age |
Italy |
M |
-2134 |
-1773 |
J1c1b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE487
|
BAIt |
Bronze Age |
Italy |
M |
-3483 |
-3107 |
H2a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE489
|
BAIt |
Bronze Age |
Italy |
M |
-2908 |
-2578 |
X2c1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE555
|
BARu |
Bronze Age |
Russia |
M |
-2857 |
-2497 |
N1a1a-T152C |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE562
|
BBC |
Copper Age |
Germany |
F |
-2458 |
-2206 |
H2a1e |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE568
|
SLV |
Iron Age |
Czech Republic |
F |
600 |
900 |
H44a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE569
|
SLV |
Iron Age |
Czech Republic |
F |
660 |
770 |
H1af |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE483
|
BAHu |
Bronze Age |
Hungary |
F |
-2000 |
-1500 |
H2a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
|
RISE484
|
BAHu |
Bronze Age |
Hungary |
F |
-2000 |
-1500 |
T1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE512
|
BARu |
Bronze Age |
Russia |
M |
-1446 |
-1298 |
U2e1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
|
RISE547
|
YAM |
Bronze Age |
Russia |
M |
-2887 |
-2634 |
T2a1a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE548
|
YAM |
Bronze Age |
Russia |
M |
-3000 |
-2400 |
U4 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE396
|
IACA |
Iron Age |
Armenia |
F |
-1192 |
-937 |
H6b |
fasta
|
7.40
|
|
FASTA
Metadata
|
|
|
RISE407
|
IACA |
Iron Age |
Armenia |
F |
-1115 |
-895 |
H8a1 |
fasta
|
33.80
|
|
FASTA
Metadata
|
|
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
|
RISE247
|
BAHu |
Bronze Age |
Hungary |
M |
-1746 |
-1611 |
H11a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
961G (MT-RNR1): Possibly DEAF-associated (Unclear)
|
RISE408
|
IACA |
Iron Age |
Armenia |
M |
-1209 |
-1009 |
I5c |
fasta
|
103.00
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
15043A (MT-CYB): MDD-associated (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16129A (MT-CR): Cyclic Vomiting Syndrome with Migraine (Reported)
|
RISE412
|
IACA |
Iron Age |
Armenia |
F |
-1193 |
-945 |
U4c1 |
fasta
|
268.90
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
RISE413
|
BACA |
Bronze Age |
Armenia |
M |
-1906 |
-1698 |
T2c1f |
fasta
|
118.20
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
-
6261A (MT-CO1): Prostate Cancer / LHON (Reported)
|
RISE416
|
BACA |
Bronze Age |
Armenia |
M |
-1643 |
-1445 |
K1a17a |
fasta
|
130.30
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE423
|
BACA |
Bronze Age |
Armenia |
M |
-1402 |
-1211 |
T2a3 |
fasta
|
133.20
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE21
|
BASC |
Bronze Age |
Denmark |
U |
-1426 |
-1281 |
N1a1a1a2 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE42
|
NESC |
Neolithic |
Denmark |
M |
-2191 |
-1972 |
H3v+16093 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE139
|
UNC |
Bronze Age |
Poland |
F |
-2135 |
-1923 |
U2e1f1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE174
|
IASC |
Iron Age |
Sweden |
F |
427 |
611 |
W1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE207
|
BASC |
Bronze Age |
Sweden |
U |
-1493 |
-1302 |
J1c8a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE492
|
IARu |
Iron Age |
Russia |
M |
-396 |
-209 |
D4b1a2a2 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE495
|
BARu |
Bronze Age |
Russia |
M |
-1414 |
-1261 |
D4j1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE496
|
BARu |
Bronze Age |
Russia |
F |
-1414 |
-1261 |
U5a1a2a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE502
|
BARu |
Bronze Age |
Russia |
F |
-1496 |
-1306 |
U5a1d |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE504
|
IARu |
Iron Age |
Russia |
F |
721 |
889 |
C4a1d |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE523
|
BARu |
Bronze Age |
Russia |
U |
-1598 |
-1398 |
M12'G |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE524
|
BARu |
Bronze Age |
Russia |
U |
-1598 |
-1398 |
J2b1a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE553
|
BARu |
Bronze Age |
Russia |
U |
-926 |
-815 |
F1b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE554
|
BARu |
Bronze Age |
Russia |
U |
-1005 |
-844 |
F1b1b |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE566
|
BBC |
Copper Age |
Czech Republic |
M |
-2279 |
-2033 |
H |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE254
|
BAHu |
Bronze Age |
Hungary |
M |
-2128 |
-1909 |
J1c9 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE559
|
BBC |
Copper Age |
Germany |
F |
-2461 |
-2207 |
H46 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE563
|
BBC |
Copper Age |
Germany |
M |
-2572 |
-2512 |
K1c1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE564
|
BBC |
Copper Age |
Germany |
M |
-2500 |
-2000 |
H-T16311C |
<NA>
|
<NA>
|
|
Metadata
|
|
|
RISE509
|
BARu |
Bronze Age |
Russia |
F |
-2887 |
-2677 |
T2c1a2 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
-
6261A (MT-CO1): Prostate Cancer / LHON (Reported)
|
RISE150
|
UNC |
Bronze Age |
Poland |
F |
-1885 |
-1693 |
U5a1b1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE510
|
BARu |
Bronze Age |
Russia |
F |
-2851 |
-2468 |
J2a2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
|
RISE511
|
BARu |
Bronze Age |
Russia |
F |
-2909 |
-2679 |
J2a2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE479
|
BAHu |
Bronze Age |
Hungary |
M |
-2000 |
-1500 |
T2b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE500
|
BARu |
Bronze Age |
Russia |
F |
-1700 |
-1500 |
U4d1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
RISE503
|
BARu |
Bronze Age |
Russia |
F |
-1727 |
-1511 |
U2e2 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
|
RISE505
|
BARu |
Bronze Age |
Russia |
F |
-1746 |
-1626 |
U4a1b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
RISE94
|
CWC |
Neolithic |
Sweden |
M |
-2621 |
-2472 |
K1a2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12192A (MT-TH): MICM / possible G15927A deafness modulator (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE560
|
BBC |
Neolithic |
Germany |
M |
-2500 |
-2000 |
U5a1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE00
|
CWC |
Neolithic |
Estonia |
F |
-2575 |
-2349 |
H5a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
4336C (MT-TQ): ADPD / Hearing Loss & Migraine / autism spectrum / intellectual disability (Unclear)
|
RISE446
|
CWC |
Neolithic |
Germany |
M |
-2829 |
-2465 |
U5b1c2 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE434
|
CWC |
Neolithic |
Germany |
M |
-2880 |
-2630 |
U4 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
RISE397
|
IACA |
Iron Age |
Armenia |
M |
-1048 |
-855 |
T1a2 |
fasta
|
192.20
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
RISE435
|
CWC |
Neolithic |
Germany |
F |
-2863 |
-2498 |
J1b1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
295T (MT-CR): Low VO2max response (Reported)
-
2158C (MT-RNR2): Reduced risk PD (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
RISE436
|
CWC |
Neolithic |
Germany |
M |
-2868 |
-2580 |
U5b1c2 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE431
|
CWC |
Neolithic |
Poland |
M |
-2286 |
-2048 |
T2e |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
|
RISE471
|
CWC |
Neolithic |
Germany |
M |
-1691 |
-1519 |
J1c1b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
3394C (MT-ND1): LHON / Diabetes / CPTdeficiency / high altitude adaptation (Reported / Population-dependent)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE371
|
BAHu |
Bronze Age |
Hungary |
F |
-2136 |
-1941 |
U5a2b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE373
|
BAHu |
Bronze Age |
Hungary |
F |
-1886 |
-1696 |
K1a2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE395
|
BARu |
Bronze Age |
Russia |
F |
-1960 |
-1756 |
U2e1h |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16183C (MT-CR): Melanoma patients (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
|
RISE386
|
BARu |
Bronze Age |
Russia |
M |
-2298 |
-2045 |
J1c1b1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
3394C (MT-ND1): LHON / Diabetes / CPTdeficiency / high altitude adaptation (Reported / Population-dependent)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
RISE394
|
BARu |
Bronze Age |
Russia |
F |
-1949 |
-1754 |
U2e1e |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16183C (MT-CR): Melanoma patients (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
|
RISE391
|
BAKa |
Bronze Age |
Kazakhstan |
F |
-2120 |
-1887 |
N1a1a1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
15043A (MT-CYB): MDD-associated (Reported)
-
16189C (MT-CR): Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients (Reported)
-
3336C (MT-ND1): Carotid atherosclerosis risk (Reported)
-
669C (MT-RNR1): DEAF (Reported)
|
I4132
|
BBC |
Copper Age |
Germany |
M |
-2500 |
-2000 |
U5a1a1 |
bam
|
187.21
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|
RISE550
|
YAM |
Bronze Age |
Russia |
M |
-3334 |
-2635 |
U5a1i |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE240
|
YAM |
Bronze Age |
Russia |
F |
-2880 |
-2632 |
U5a1d1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
RISE586
|
UNC |
Bronze Age |
Czech Republic |
F |
-2300 |
-1800 |
K1b1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15257A (MT-CYB): LHON (Conflicting reports)
-
16093C (MT-CR): Cyclic Vomiting Syndrome (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
RISE109
|
UNC |
Bronze Age |
Poland |
F |
-1954 |
-1772 |
U4 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
I5024
|
BBC |
Copper Age |
Czech Republic |
M |
-2278 |
-2032 |
H3 |
bam
|
109.65
|
|
FASTA
Metadata
|
|
|
I5025
|
BBC |
Copper Age |
Czech Republic |
F |
-2500 |
-1900 |
U5b2c |
bam
|
1116.00
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|
I5017
|
BBC |
Copper Age |
Germany |
F |
-2460 |
-2206 |
H46 |
bam
|
147.85
|
|
FASTA
Metadata
|
|
-
16192T (MT-CR): Melanoma patients (Reported)
|
I5021
|
BBC |
Copper Age |
Germany |
M |
-2571 |
-2341 |
K1c1 |
bam
|
140.81
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
I5022
|
BBC |
Copper Age |
Germany |
M |
-2500 |
-2000 |
HV+16311 |
bam
|
709.38
|
|
FASTA
Metadata
|
|
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
|